Install
Latest in Cancer Prevention & Screening
Cancer Prevention & Screening at a glance
The 10 latest articles on Cancer Prevention & Screening come from 7 sources, published between Oct 29 and Nov 13. Most come from BIOENGINEER.ORG (4).
Organizations: American Cancer Society (3), CRC (2)
Beyond MSI Status: A New Biomarker of Immunotherapy Resistance in Colorectal Cancer
Immune checkpoint inhibitors have transformed the treatment of mismatch repair-deficient/microsatellite instability-high (dMMR/MSI) colorectal cancer, producing durable responses in many patients. However, not all patients with dMMR/MSI tumors benefit from immunotherapy, while the majority of patients with mismatch…
The impact of Movember on men’s health
HEALTHY LIVING The impact of Movember on men’s health Published 2 hours ago on 11/12/2026 By bowienews Who would have thought an informal idea between two friends enjoying a drink in a pub in Melbourne, Australia, back in 2003 would transform into a…
Mailed Stool Tests Lifted Colon Cancer Screening at San Diego Community Clinics for Two Years Before Gains Faded
Conditions Mailed Stool Tests Lifted Colon Cancer Screening at San Diego Community Clinics for Two Years Before Gains Faded Published Nov 09, 2026 9:30 AM EST By Elena Vega iStock | clubfoto Mailing at-home stool tests to patients raised colorectal cancer screening rates at…
Men’s Health Awareness Month: New Screening Options Make Colorectal Cancer Detection Easier
Search Posts Recent Posts Splittin’ the Atom – Nov. 12, 2026 – Commentary with Jen November 12, 2026 Rhode Island Weather for November 12, 2026 (storm outlook) November 12, 2026 Men’s Health Awareness Month: New Screening Options Make Colorectal Cancer Detection Easier November 12, 2026 Newport Naval War College given 33 Military Education…
Movember 2026 | Movember must be about more than starting conversations
Running throughout November, Movember 2026 is a global movement dedicated to changing the face of men’s health and helping men live happier, healthier and longer lives. The campaign focuses on three key areas: men’s mental health and suicide prevention, prostate cancer…
Iterion Therapeutics Expands Clinical Development of Tegavivint, a First-in-Class Wnt/β-Catenin Inhibitor, into Colorectal Cancer with First Patient Dosed
News provided by Iterion Therapeutics Mar 25, 2026, 08:09 ET Tegavivint Targets the Central Oncogenic Driver in Colorectal Cancer as First-in-Class Clinical-Stage Wnt/β-Catenin Inhibitor CRC Expansion Builds on Promising Monotherapy Activity and Favorable Safety Profile Observed in Advanced Hepatocellular Carcinoma HOUSTON, March…
Cancer Prevention & Screening
Testicular checks, skin exams, colon and prostate risk discussions and timing.
- 3 Tracked terms
- Last 30 days Feed window
What this topic collects on
An article joins this feed when it matches these terms. Each one is also a search of its own.